9 July 2018 - - Florence, Italy-based global pharmaceutical company Menarini Group subsidiary Menarini Asia-Pacific Holdings Pte Ltd and Espoo, Finland-based global pharmaceutical company Orion Corp. (NASDAQ: ORN; ORNBV:Helsinki) have signed a multi-year licensing agreement for Menarini Asia-Pacific to distribute and commercialize several of Orion's Easyhaler products in 10 countries in Asia-Pacific region, the companies said.
The countries involved in the partnership are China, Hong Kong, Philippines, Malaysia, Indonesia, Thailand, Singapore, Vietnam, Taiwan, and South Korea.
Orion's proprietary dry-powder inhaler Easyhaler is used for administering medication for the treatment of asthma and COPD.
The Menarini Group employs over 17,000 employees in more than 100 countries. Menarini Asia-Pacific operates across the entire commercial value chain, from clinical development, regulatory approval, and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in many therapeutic fields.
With approximately 3,200 employees, Orion develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods within the core therapy areas of central nervous system disorders, oncology, and respiratory diseases.